A Group A variant-like antigen has been detected in streptococci belonging to Groups D, E, G, M, and N. In Groups D and N the variant-like antigen was located in the streptococcal cell walls. In two strains of Group N streptococci (C559 and B209) the cell walls were chemically different and serologically distinct. In strain C559 N-acetylgalactosamine, and in strain B209, N-acetylglucosamine were the major determinants of serological specificity. The cell walls of strain C559 contained at least three serologically reactive components: a rhamnose-containing fraction that precipitated with an antiserum to Group A-variant carbohydrate; a strain-specific polysaccharide composed of galactosamine and glucosamine, both in the N-acetylated form and probably polymerized with an unidentified phosphorylated substance; and a component of unknown composition serologically related to a Group D streptococcus strain C3 (S. durans). An analogy is drawn between the cell wall structure in streptococcus and Salmonella.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138942 | PMC |
| http://dx.doi.org/10.1084/jem.133.3.479 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Optimal sequence-based design for multi-antigen HIV-1 vaccines using minimally distant antigens.
PLoS Comput Biol
October 2022
U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
The immense global diversity of HIV-1 is a significant obstacle to developing a safe and effective vaccine. We recently showed that infections established with multiple founder variants are associated with the development of neutralization breadth years later. We propose a novel vaccine design strategy that integrates the variability observed in acute HIV-1 infections with multiple founder variants.
View Article and Find Full Text PDFPost-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor.
J Biol Chem
October 2015
From the Laboratories for Reproductive Biology, Department of Pediatrics, Lineberger Comprehensive Cancer Center, Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina 27599
Article Synopsis
- MAGE-A11 is a protein that acts as a coactivator for the androgen receptor and plays a role in the growth of castration-resistant prostate cancer, being found at low levels in normal reproductive tissues.
- The tumor suppressor p14-ARF promotes the degradation of MAGE-A11 independently of lysine ubiquitination, which helps maintain low levels of MAGE-A11 in healthy cells and reduces androgen receptor activity.
- Elevated MAGE-A11 levels, when p14-ARF is low, contribute to increased transcriptional activity of both the androgen receptor and E2F1, potentially leading to castration-resistant prostate cancer development.
Characterization of a Pseudomonas putida rough variant evolved in a mixed-species biofilm with Acinetobacter sp. strain C6.
J Bacteriol
July 2007
Infection Microbiology Group, BioCentrum-DTU, Technical University of Denmark, DK-2800 Lyngby, Denmark.
Genetic differentiation by natural selection is readily observed among microbial populations, but a more comprehensive understanding of evolutionary forces, genetic causes, and resulting phenotypic advantages is not often sought. Recently, a surface population of Pseudomonas putida bacteria was shown to evolve rapidly by natural selection of better-adapted variants in a mixed-species biofilm consortium (S. K.
View Article and Find Full Text PDFA Group A variant-like antigen has been detected in streptococci belonging to Groups D, E, G, M, and N. In Groups D and N the variant-like antigen was located in the streptococcal cell walls. In two strains of Group N streptococci (C559 and B209) the cell walls were chemically different and serologically distinct.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!